Simplex Trading, LLC Zymeworks Inc. Transaction History

Simplex Trading, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$4.65 - $7.43 $80,389 - $128,449	-17,288 Reduced 33.02%	35,070 $215,000
Q2 2022 Aug 03, 2022	BUY	$4.82 - $7.7 $55,497 - $88,657	11,514 Added 28.19%	52,358 $277,000
Q1 2022 May 02, 2022	BUY	$6.0 - $16.98 $237,228 - $671,355	39,538 Added 3027.41%	40,844 $267,000
Q3 2021 Oct 28, 2021	SELL	$27.35 - $37.28 $9,381 - $12,787	-343 Reduced 20.8%	1,306 $48,000
Q2 2021 Aug 12, 2021	SELL	$26.5 - $38.23 $101,389 - $146,267	-3,826 Reduced 69.88%	1,649 $57,000
Q1 2021 Apr 26, 2021	BUY	$29.83 - $56.81 $102,436 - $195,085	3,434 Added 168.25%	5,475 $172,000
Q4 2020 Feb 02, 2021	BUY	$39.12 - $54.99 $79,843 - $112,234	2,041 New	2,041 $96,000
Q1 2020 Apr 29, 2020	SELL	$24.28 - $49.8 $956,122 - $1.96 Million	-39,379 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$24.84 - $45.46 $584,907 - $1.07 Million	23,547 Added 148.73%	39,379 $1.79 Million
Q3 2019 Oct 15, 2019	BUY	$22.78 - $29.08 $77,246 - $98,610	3,391 Added 27.26%	15,832 $392,000
Q2 2019 Jul 26, 2019	BUY	$15.0 - $22.49 $178,425 - $267,518	11,895 Added 2178.57%	12,441 $273,000
Q1 2019 Apr 18, 2019	BUY	$14.02 - $16.74 $5,523 - $6,595	394 Added 259.21%	546 $0
Q4 2018 Jan 16, 2019	BUY	$10.95 - $15.44 $1,664 - $2,346	152 New	152 $2,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $766M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.